Overall patients | Matched population | |||||
---|---|---|---|---|---|---|
Survival group (N = 42) | Death group (N = 16) | P value | Survival group (N = 15) | Death group (N = 15) | P value | |
IABP | 18(42.86%) | 12(75%) | 0.029 | 4(26.67%) | 11(73.33%) | 0.027 |
CRRT | 5(11.90%) | 9(56.25%) | < 0.001 | 0(0%) | 9(60%) | < 0.001 |
FFP, ml | 3260(3290) | 13,552(25,450) | 0.050 | 3260(3120) | 11,600(21,790) | 0.071 |
Red blood cell, unit | 8(5.5) | 14(19.75) | 0.201 | 7.8(4.5) | 13.5(24) | 0.194 |
Platelet transfusion | 4(9.52%) | 7(43.75%) | 0.009 | 0(0%) | 6(40%) | 0.017 |
Cryoprecipitate transfusion | 17(40.48%) | 6(37.5%) | 0.836 | 4(26.67%) | 6(40%) | 0.700 |
Time of re-exploration, min | 130(45) | 225(64) | 0.002 | 148.73 ± 30.93 | 212.47 ± 84 | 0.010 |